VEGFA and glioblastoma: Similar studies with diverse VEGF inhibitors have generally corroborated this conclusion, namely, that current VEGF inhibitors alone are insufficient to fully suppress angiogenesis in glioblastoma, and their use has not been associated with a significant improvement in OS [62, 63].